NASD · Healthcare · Biotechnology · USA
Legend Biotech Corp ADR is a mid cap company (market value between $2 billion and $10 billion) in the Biotechnology industry.
Intrinsic value, DCF valuation, financial health and value investing analysis for the Legend Biotech Corp ADR stock.
Overvalued: intrinsic value $7.04 per share, market price $16.11, margin of safety -128.9% (as of 2026-11-17).
Discounting its cash flows at 8.5% (average of 2 methods) values the shares at $7.04; the price of $16.11 is 129% above that value, and 79% of that value comes from beyond year five.
5 more funds hold it; the full list is part of the paid plan.
61 more in this industry show a wider margin of safety.
LEGN is overvalued (as of the 2026-11-17 close). Discounting its cash flows at 8.5% (average of 2 methods) values the shares at $7.04; the price of $16.11 is 129% above that value, and 79% of that value comes from beyond year five.
$7.04 per share (as of the 2026-11-17 close), against a market price of $16.11. That is a margin of safety of -128.9%. The value is the average of the 2 valuation methods that apply to this company, recomputed every night after the US close.